LSDIF (Lucy Scientific Discovery) Net Income From Continuing Operations: $-10.23 Mil (TTM As of Dec. 2023)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Lucy Scientific Discovery Net Income From Continuing Operations?

Lucy Scientific Discovery LSDIF Net Income From Continuing Operations is $-10.23 Mil as of Dec. 2023.

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Lucy Scientific Discovery's net income from continuing operations for the three months ended in Dec. 2023 was $-1.08 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in Dec. 2023 was $-10.23 Mil.

Lucy Scientific Discovery Net Income From Continuing Operations Historical Data

* Premium members only.

The historical data trend for Lucy Scientific Discovery's Net Income From Continuing Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lucy Scientific Discovery Net Income From Continuing Operations Chart

Lucy Scientific Discovery Annual Data
Trend Jun21 Jun22 Jun23
Net Income From Continuing Operations
-4.73 -5.86 -8.99

Lucy Scientific Discovery Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Net Income From Continuing Operations Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only -0.47 -4.57 -2.58 -2.00 -1.08

Lucy Scientific Discovery Net Income From Continuing Operations Calculation

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Net Income From Continuing Operations for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-10.23 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Net Income From Continuing Operations of $-10.23 Mil mean?
Lucy Scientific Discovery (LSDIF) has a Net Income From Continuing Operations of $-10.23 Mil as of Dec. 2023. The total net income from continuing operations as record on a company's cash-flow statement. View historical data for Lucy Scientific Discovery and its competitors.
Is Lucy Scientific Discovery's Net Income From Continuing Operations too high?
Lucy Scientific Discovery's current Net Income From Continuing Operations is $-10.23 Mil.
How does Lucy Scientific Discovery's Net Income From Continuing Operations compare to INQD and ZTS?
Lucy Scientific Discovery's Net Income From Continuing Operations of $-10.23 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Income From Continuing Operations for a Drug Manufacturers company?
A good Net Income From Continuing Operations depends on the Drug Manufacturers industry context. However, Net Income From Continuing Operations should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Income From Continuing Operations mean?
A high Net Income From Continuing Operations can signal that a stock is expensive relative to its fundamentals. The total net income from continuing operations as record on a company's cash-flow statement. View historical data for Lucy Scientific Discovery and its competitors. Lucy Scientific Discovery's current Net Income From Continuing Operations is $-10.23 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lucy Scientific Discovery stock overvalued right now?
Lucy Scientific Discovery (LSDIF) has a current Net Income From Continuing Operations of $-10.23 Mil. The current Net Income From Continuing Operations is $-10.23 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Income From Continuing Operations calculated?
Net Income From Continuing Operations is calculated from a company's financial statements. For Lucy Scientific Discovery (LSDIF), the current Net Income From Continuing Operations is $-10.23 Mil as of Dec. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Lucy Scientific Discovery Business Description

Address 301-1321 Blanshard Street, Victoria, BC, CAN, V8W 0B6
Lucy Scientific Discovery Inc is an early-stage psychotropics contract manufacturing company focused on becoming the contract research, development, and manufacturing organization for the emerging psychotropics-based medicines industry. Its drug products are designed to treat a range of mental health and cognitive conditions.